Status:
COMPLETED
Open to Laparoscopic Reverse Conversion of Perforated Appendicitis
Lead Sponsor:
Zagazig University
Conditions:
Laparoscopic Surgery
Acute Appendicitis With Rupture
Eligibility:
All Genders
16-65 years
Phase:
NA
Brief Summary
A Prospective Randomized Controlled Trial of Reverse Conversion (Open to Laparoscopic) in management of Acute Perforated Appendicitis
Detailed Description
Introduction: Acute appendicitis (AA), a frequent intra-abdominal surgical pathology, necessitates a thorough awareness of its symptoms, examination, diagnosis, and total surgical management. The surg...
Eligibility Criteria
Inclusion
- symptoms consistent with acute perforated appendicitis,
- had ultrasound or computed tomography (CT) evidence of acute perforated appendicitis,
- ages ranging from 16 to 65 years.
Exclusion
- radiological evidence of appendicular mass,
- septic shock or multi-organ failure (MOF) at presentation,
- Diabetes Mellitus (DM), renal failure, morbid obesity
- recent (6-month) history of thromboembolic disease
- immunomodulators,
- a history of inflammatory bowel disease (IBD),
- postoperative pathological report of the removed appendix revealed carcinoid or Crohn's disease,
- American Society of Anesthesiology (ASA) classification more than II.
Key Trial Info
Start Date :
January 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 25 2021
Estimated Enrollment :
426 Patients enrolled
Trial Details
Trial ID
NCT05283733
Start Date
January 18 2018
End Date
December 25 2021
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University
Zagazig, Egypt